Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 5, 2024
Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosis
Paul McNally, Alvin Singh, Susanna A McColley, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2002
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci
Violeta Rodriguez-Cerrato, Cindy C McCoig, Jesus Saavedra, et al.
Pharmaceutics
|
July 27, 2024
Functional Mechanisms of Dietary Crocin Protection in Cardiovascular Models under Oxidative Stress
Sepideh Zununi Vahed, Marisol Zuluaga Tamayo, Violeta Rodriguez-Ruiz, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
July 2, 2016
In vitro and in vivo hemocompatibility evaluation of a new dermatan sulfate-modified PET patch for vascular repair surgery
Manel Dhahri, Violeta Rodriguez-Ruiz, Rachida Aid-Launais, et al.
Marine Drugs
|
May 12, 2015
Astaxanthin from Haematococcus pluvialis Prevents Oxidative Stress on Human Endothelial Cells without Toxicity
Philippe Régnier, Jorge Bastias, Violeta Rodriguez-Ruiz, et al.
Transgender Health
|
May 14, 2026
Microbiota, Gender-Affirming Hormone Therapy, and Inflammatory Biomarkers in Transgender Women with HIV: Potential Implications for Cardiovascular Disease
Tiffany R Glynn, Courtney A Broedlow, Violeta Rodriguez, et al.
Molecules (Basel, Switzerland)
|
October 14, 2018
Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity
Violeta Rodriguez-Ruiz, José Ángel Salatti-Dorado, Abolfazl Barzegari, et al.
The Lancet. Respiratory Medicine
|
January 5, 2025
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
Jordana E Hoppe, Ajay S Kasi, Jessica E Pittman, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society
|
April 5, 2024
Safety and efficacy of ivacaftor in infants aged 1 to less than 4 months with cystic fibrosis
Paul McNally, Alvin Singh, Susanna A McColley, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2002
Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci
Violeta Rodriguez-Cerrato, Cindy C McCoig, Jesus Saavedra, et al.
Pharmaceutics
|
July 27, 2024
Functional Mechanisms of Dietary Crocin Protection in Cardiovascular Models under Oxidative Stress
Sepideh Zununi Vahed, Marisol Zuluaga Tamayo, Violeta Rodriguez-Ruiz, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
July 2, 2016
In vitro and in vivo hemocompatibility evaluation of a new dermatan sulfate-modified PET patch for vascular repair surgery
Manel Dhahri, Violeta Rodriguez-Ruiz, Rachida Aid-Launais, et al.
Marine Drugs
|
May 12, 2015
Astaxanthin from Haematococcus pluvialis Prevents Oxidative Stress on Human Endothelial Cells without Toxicity
Philippe Régnier, Jorge Bastias, Violeta Rodriguez-Ruiz, et al.
Transgender Health
|
May 14, 2026
Microbiota, Gender-Affirming Hormone Therapy, and Inflammatory Biomarkers in Transgender Women with HIV: Potential Implications for Cardiovascular Disease
Tiffany R Glynn, Courtney A Broedlow, Violeta Rodriguez, et al.
Molecules (Basel, Switzerland)
|
October 14, 2018
Astaxanthin-Loaded Nanostructured Lipid Carriers for Preservation of Antioxidant Activity
Violeta Rodriguez-Ruiz, José Ángel Salatti-Dorado, Abolfazl Barzegari, et al.
The Lancet. Respiratory Medicine
|
January 5, 2025
Vanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial
Jordana E Hoppe, Ajay S Kasi, Jessica E Pittman, et al.
Page
of 2